NCT04714034

Brief Summary

Development and validation of questionnaire/scale to assess problematic online dating app (ODA) use in a sub-cohort of the SwissPrEPared cohort study (validation sample: n=229). Longitudinal design to assess the association of problematic ODA use and sexual/mental health and substance use outcomes. No randomised trial, only 1 cohort which will be stratified according to severity/risk of problematic ODA use.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
229

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 13, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 19, 2021

Completed
8 months until next milestone

Study Start

First participant enrolled

September 23, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2024

Completed
Last Updated

January 31, 2025

Status Verified

January 1, 2025

Enrollment Period

1.3 years

First QC Date

December 13, 2020

Last Update Submit

January 28, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Develop and validate a scale measuring problematic online dating app (ODA) use

    Scale development and validation will follow the FDA guidance for patient-reported outcomes and recommendations on questionnaire research. Preliminary testing, pilot-testing, and validation will be conducted in participants from the SwissPrEPared Study

    single measurement (one day per participant)

  • Associated mental, sexual health and substance use outcomes of problematic ODA use

    Evaluate the association of problematic ODA use with: Sexual health outcomes (incident cases of STI, such as syphilis, gonorrhoea and chlamydia, or HIV), over 6 months Mental health outcomes: prevalence of psychiatric disorders, measured at baseline and 12 months, using validated questionnaires Substance use outcomes: Lifetime, 12-month, 3-month prevalence and frequency rates

    6 months

Study Arms (1)

HIV-negative SwissPrePared participants who are active Online Dating App (ODA) users

Diagnostic Test: to develop and validate a scale measuring problematic online dating app (ODA) use in sexual minorities

Interventions

Qualitative part: scale development and validation with testing in 3 different participant samples, i.e. preliminary testing (n=10), pilot testing (n=30-60), validation (n=300). Quantitative part: longitudinal part conducted in the validation sample of the qualitative study part (n=300) with the aim to evaluate the association of scores in the problematic ODA use scale with sexual health and mental health outcomes.

HIV-negative SwissPrePared participants who are active Online Dating App (ODA) users

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

HIV-negative SwissPrEPared participants (≥ 18 years old) who are active online dating app users.

You may qualify if:

  • currently engaging in online dating (i.e., using applications/websites with the aim to meet potential relationship or sexual partners or having used them actively in the past 12 months)
  • Participating in the SwissPrEPared study at center Checkpoint Zurich
  • German speaking

You may not qualify if:

  • \- Potential participants will be excluded if they are unable to follow study procedures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Epidemiology, Biostatistics and Prevention Institute

Zurich, Canton of Zurich, 8001, Switzerland

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 13, 2020

First Posted

January 19, 2021

Study Start

September 23, 2021

Primary Completion

December 31, 2022

Study Completion

July 31, 2024

Last Updated

January 31, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations